Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44) : a randomised phase 3 trial

DSpace Repository

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44) : a randomised phase 3 trial

Author: Untch, Michael; Kühn, Thorsten
Tübinger Autor(en):
Kühn, Thorsten
Published in: Lancet Oncology (2012), Bd. 13, H. 2, S. 135-144
Verlagsangabe: Oxford : Elsevier
Language: English
Full text: http://dx.doi.org/10.1016/S1470-2045(11)70397-7
ISSN: 1470-2045
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)